Narrative review examines biologic-induced cutaneous pseudolymphomas in psoriasis, highlighting a unique case of brodalumab.
The authors provide a concise narrative review of biologic-induced cutaneous pseudolymphomas and illustrate the topic with the first reported case of brodalumab-induced pseudolymphoma in a patient with psoriasis.
No takes yet. Share an insight, caveat, or question.
Almeida-Silva et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: